Is it possible to stop follow-up of patients with primary T1G3 urothelial carcinoma of the bladder managed with intravesical bacille Calmette–Guérin immunotherapy?

详细信息    查看全文

• 作者：Thomasz Golabek ; Joan Palou ; Oscar Rodríguez ; Josep Maria Gaya…
• 关键词：Bacille Calmette–Guérin ; Bladder cancer ; Disease recurrence ; Progression ; T1G3 ; Upper urinary tract
• 刊名：World Journal of Urology
• 出版年：2017
• 出版时间：February 2017
• 年：2017
• 卷：35
• 期：2
• 页码：237-243
• 全文大小：
• 刊物类别：Medicine
• 刊物主题：Urology; Nephrology; Oncology;
• 出版者：Springer Berlin Heidelberg
• ISSN：1433-8726
• 卷排序：35

文摘

BackgroundRecurrence and progression of T1 grade 3 (T1G3) urothelial bladder carcinomas (UBCs) treated with bacille Calmette–Guérin (BCG) are common events, but the long-term follow-up of the disease remains controversial.